How apps, platforms and tests are empowering individuals with data-driven insights and helping them to optimize health and prolong vitality.
We recently published our Ten Levels of Longevity framework, which provides a comprehensive guide to understanding the expanding field of longevity therapies. As we explore each of these levels, we turn our focus to Level 2: consumer diagnostics. This stage involves leveraging biological samples, lifestyle assessments and digital data, alongside AI technologies, to uncover actionable insights that can guide both medical and lifestyle-based strategies for extending one’s healthspan.
Level 2: consumer diagnostics
Use of biological samples, lifestyle questionnaires, digital information and AI to identify opportunities for both clinical and lifestyle interventions to improve healthspan.
Consumer diagnostics involve the analysis of various data sources – such as blood samples, genetic information and lifestyle habits – to provide personalized health insights. By leveraging AI and machine learning, these diagnostics can interpret complex datasets, offering individuals tailored recommendations to improve their health and potentially extend their lifespan.
A significant trend in this domain is the development of multiomics platforms that integrate genomics, proteomics, metabolomics and other omics data to create comprehensive health profiles. These platforms aim to translate scientific research into consumer-friendly products, enabling individuals to monitor and manage their health proactively. However, it should be noted that while some consumer diagnostics are not yet clinically validated, the industry is continuing to focus on identifying deeper biomarkers for clinical and biotech applications.
Investment opportunities in consumer diagnostics
The consumer diagnostics sector presents promising investment opportunities, particularly in companies that are bridging the gap between consumer health products and mainstream clinical practice. Investing in firms that develop deeply evidenced protocols based on extensive biobank data can be advantageous, and these companies are at the forefront of integrating scientific research with practical applications, potentially revolutionizing personalized healthcare.
Companies active at Level 2
GlycanAge
Glycan Age offers a biological age test that measures chronic inflammation by analyzing immunoglobulin G (IgG) protein glycosylation patterns in blood. This test provides insights into how lifestyle factors influence aging, enabling targeted interventions to improve healthspan.
TruDiagnostic
TruDiagnostic offers TruAge, a comprehensive biological age assessment analyzing over 900,000 methylation markers. This test provides insights into telomere length, intrinsic and extrinsic aging, immune cell composition and aging rate.
Lifeforce
Lifeforce uses biomarkers and proprietary algorithms to provide users with a “Lifescore,” a metric that reflects their overall health. Based on this score, users receive personalized health plans developed with the assistance of clinicians and health coaches.
Deep Longevity
Deep Longevity has developed the “Blood Age” test, which uses standard clinical blood reports to predict biological age. Its AI algorithms analyze various blood biomarkers to identify factors accelerating or decelerating the aging process.
Humanity Health
Humanity Health offers a digital app that tracks users’ health data and lifestyle habits, generating a proprietary aging score. The app provides recommendations to slow down the aging process, empowering individuals to make informed choices for healthier aging.
Check out our look at Level 1 (lifestyle management) HERE and stay tuned for Levels 3 to 10 coming over the next few weeks!
